Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aptevo Therapeutics Inc. Director's Dealing 2023

Mar 7, 2023

35422_dirs_2023-03-07_90e5da13-8e4c-43b2-a75e-a9e637f1a4f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2023-03-03

Reporting Person: Taylor Daphne (SVP, CFO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3840 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Unit $ Common Stock (792) Direct
Restricted Stock Unit $ Common Stock (4750) Direct
Restricted Stock Unit $ Common Stock (13889) Direct
Stock Option (right to buy) $6.97 2030-02-18 Common Stock (2400) Direct
Stock Option (right to buy) $8.56 2030-07-27 Common Stock (514) Direct
Stock Option (right to buy) $8.56 2030-07-27 Common Stock (514) Direct
Stock Option (right to buy) $8.56 2030-07-27 Common Stock (516) Direct
Stock Option (right to buy) $8.56 2030-07-27 Common Stock (839) Direct
Stock Option (right to buy) $33.50 2031-01-29 Common Stock (7125) Direct
Stock Option (right to buy) $5.30 2032-03-04 Common Stock (4750) Direct

Footnotes

F1: The Restricted Stock Units ("RSUs") vest in three approximately equal annual installments beginning on January 29, 2022. The RSUs were granted on January 29, 2021. As of the date of this filing, all but 792 shares had vested.

F2: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F3: The RSUs vest in three approximately equal annual installments beginning on March 4, 2023. The RSUs were granted on June 7, 2022.

F4: The RSUs vest in two approximately equal annual installments beginning the day immediately prior to the annual anniversary of the grant date. The RSUs were granted on August 9, 2022.

F5: The option vests in three approximately equal annual installments beginning on February 18, 2021. The option was granted on February 18, 2020.

F6: The option vests in three approximately equal annual installments beginning on July 27, 2021. The option was granted on July 27, 2020.

F7: The option vests in three approximately equal annual installments beginning on January 29, 2022. The option was granted on January 29, 2021.

F8: The option vests in three approximately equal annual installments beginning on March 4, 2023. The option was granted on March 4, 2022.